Why Novo Nordisk Stock Popped on Tuesday
If you can't beat Novo Nordisk, maybe you should join 'em?
Novo Nordisk (NYSE: NVO) stock jumped 3% through 10:55 a.m. Tuesday on some potentially positive news in the GLP-1 weight loss market.
As Reuters reports today, an online weight loss company called Noom has begun selling smaller doses of compounded versions of Novo Nordisk's Wegovy GLP-1 drug. This development comes as the compounding pharmacy industry seeks a way to coexist with the big pharmaceutical companies that invented -- and patented -- GLP-1 drugs in the first place.
Image source: Getty Images.
